EQUILLIUM, INC. Earnings Per Share, Basic and Diluted
EQUILLIUM, INC. (EQ) reported Earnings Per Share, Basic and Diluted of -$1.17 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- EQUILLIUM, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$1.17.
- EQUILLIUM, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.36.
- EQUILLIUM, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.35.
- EQUILLIUM, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.31.
- EQUILLIUM, INC. earnings per share, basic and diluted for fiscal 2021 was -$1.36.
- EQUILLIUM, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.46.
- EQUILLIUM, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.47.
- EQUILLIUM, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.09.
| Period end | Earnings Per Share, Basic and Diluted 0 month | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 7 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 10 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$1.17 10-Q · filed 2022-05-12 | -$1.57 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$1.93 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$2.25 derived: net income ÷ weighted average shares · filed 2023-11-08 | |||
| 2021-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.71 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.03 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.36 10-K · filed 2022-03-23 | |||
| 2021-09-30 | -$0.35 10-Q · filed 2021-11-10 | -$0.67 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.99 10-Q · filed 2021-11-10 | -$1.35 derived: net income ÷ weighted average shares · filed 2022-11-14 | |||
| 2021-06-30 | -$0.31 10-Q · filed 2021-08-10 | -$0.64 10-Q · filed 2021-08-10 | -$1.00 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$1.31 derived: net income ÷ weighted average shares · filed 2022-11-14 | |||
| 2021-03-31 | -$0.33 10-Q · filed 2022-05-12 | -$0.69 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$1.00 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$1.36 derived: net income ÷ weighted average shares · filed 2022-11-14 | |||
| 2020-12-31 | -$0.36 10-K · filed 2021-03-24 | -$0.67 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$1.03 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$1.46 10-K · filed 2022-03-23 | |||
| 2020-09-30 | -$0.31 10-Q · filed 2021-11-10 | -$0.67 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$1.11 10-Q · filed 2021-11-10 | -$1.54 derived: net income ÷ weighted average shares · filed 2021-11-10 | |||
| 2020-06-30 | -$0.37 10-Q · filed 2021-08-10 | -$0.81 10-Q · filed 2021-08-10 | -$1.25 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$1.59 derived: net income ÷ weighted average shares · filed 2021-11-10 | |||
| 2020-03-31 | -$0.45 10-Q · filed 2021-05-13 | -$0.88 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$1.23 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$1.58 derived: net income ÷ weighted average shares · filed 2021-11-10 | |||
| 2019-12-31 | -$0.44 10-K · filed 2021-03-24 | -$0.78 derived: net income ÷ weighted average shares · filed 2021-03-24 | -$1.13 derived: net income ÷ weighted average shares · filed 2021-03-24 | -$1.47 10-K · filed 2021-03-24 | |||
| 2019-09-30 | -$0.35 10-K · filed 2021-03-24 | -$0.70 derived: net income ÷ weighted average shares · filed 2021-03-24 | -$1.04 10-Q · filed 2020-11-10 | -$1.35 derived: net income ÷ weighted average shares · filed 2021-03-24 | |||
| 2019-06-30 | -$0.35 10-K · filed 2021-03-24 | -$0.69 10-Q · filed 2020-08-12 | -$1.00 derived: net income ÷ weighted average shares · filed 2021-03-24 | -$1.41 derived: net income ÷ weighted average shares · filed 2021-03-24 | |||
| 2019-03-31 | -$0.34 10-K · filed 2021-03-24 | -$0.65 derived: net income ÷ weighted average shares · filed 2021-03-24 | -$1.06 derived: net income ÷ weighted average shares · filed 2021-03-24 | -$1.27 derived: net income ÷ weighted average shares · filed 2021-03-24 | |||
| 2018-12-31 | -$0.31 10-K · filed 2020-03-26 | -$0.73 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.92 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$1.09 10-K · filed 2020-03-26 | |||
| 2018-09-30 | -$0.44 10-K · filed 2020-03-26 | -$0.61 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.76 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | -$0.16 10-K · filed 2020-03-26 | -$0.31 10-Q · filed 2019-08-12 | |||||
| 2018-03-31 | -$0.15 10-K · filed 2020-03-26 | ||||||
| 2017-12-31 | -$0.10 10-K · filed 2019-03-27 | -$0.22 10-K · filed 2019-03-27 | |||||
| 2017-09-30 | -$0.01 10-K · filed 2019-03-27 | -$0.16 10-Q · filed 2018-11-15 | |||||
| 2017-06-30 | -$0.10 10-K · filed 2019-03-27 | ||||||
| 2017-03-31 | -$0.01 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |